Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Is The Herceptin Market Expected To Grow In Terms Of Size?

The market size of herceptin has experienced robust growth in the last few years. The market is set to increase from $7.1 billion in 2024 to $7.48 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 5.4%. The historical growth of the market can be attributed to factors such as regulatory approvals, an increase in breast cancer cases, advancements in monoclonal antibody technology, positive clinical trial results, and higher healthcare spending.

In the incoming years, the herceptin market is projected to experience robust growth, ballooning to $9.38 billion by 2029 with a compound annual growth rate (CAGR) of 5.8%. Several factors are contributing to this growth during the predicted period, including the proliferation of biosimilars, the escalating use of targeted therapies, increased accessibility to healthcare in emerging markets, continuous oncology research and development, and a rise in incidents of HER2-positive cancers. The forecasted period also sees notable trends such as the creation of antibody-drug conjugates, progress in biosimilar formulations, incorporation of AI in pharmaceutical discovery, individualized medicine protocols, and enhancements in drug delivery systems.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24236&type=smp

What Market Forces Are Contributing To The Growth Of The Herceptin Market?

The herceptin market’s expansion is expected to be driven by a rising incidence of breast cancer. This form of cancer, which originates from the cells of the breast, typically in the milk ducts or lobules, includes HER2-positive breast cancer, invasive ductal carcinoma (IDC), and invasive lobular carcinoma (ILC). Alcohol consumption, inadequate diet, and a lack of physical exercise are among the lifestyle changes contributing to an increased risk and, consequently, a surge in breast cancer incidence. This surge, particularly in HER2-positive diagnoses, is correspondingly boosting the demand for targeted therapies like herceptin. For instance, it is projected by the American Cancer Society, a US-based cancer organization, that there will be around 319,750 fresh cases of breast cancer and approximately 42,680 deaths from it in January 2025. Therefore, the rise in breast cancer incidents is fuelling the growth of the herceptin market.

How Is The Herceptin Market Segmented Across Key Categories?

The herceptinmarket covered in this report is segmented –

1) By Product: Biologic; Biosimilar

2) By Application: Breast Cancer; Gastric Cancer

3) By Payer: Commercial And Private; Public

4) By Distribution Channel: Hospital Pharmacy; Specialty Pharmacy

Subsegments:

1) By Biologic: Intravenous (IV) Biologics; Subcutaneous (SC) Biologic

2) By Biosimilar: Intravenous (IV) Biosimilars; Subcutaneous (SC) Biosimilars

What Key Trends Are Driving Growth In The Herceptin Market?

Leading corporations in the herceptin market are pioneering new treatment alternatives, including unique biosimilar products, to boost patient accessibility and improve results in the treatment of HER2-positive cancers. These innovative biosimilar products are nearly identical variants of approved biologic drugs, developed utilizing cutting-edge biotechnology to maintain safety, efficacy, and quality. In April 2024, for example, US-based Pharma company, Accord BioPharma Inc., obtained approval from the U.S. Food and Drug Administration for HERCESSI (trastuzumab-strf), a herceptin (trastuzumab) biosimilar used to treat HER2-overexpressing breast and gastric cancers. Biosimilars like HERCESSI show analogous efficacy and safety compared to their original biologics, while potentially providing more economical treatment options.

Who Are The Major Stakeholders Operating In The Herceptin Market?

Major companies operating in the herceptin market are Pfizer Inc., Roche Holding AG, Merck & Co Inc., GlaxoSmithKline plc, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim GmbH, Genentech Inc., Dr. Reddy’s Laboratories, Celltrion Healthcare, Mundipharma, Biocon Limited, Bio-Techne Corporation, Samsung Bioepis Co Ltd, AryoGen Pharmed, InvivoGen, Abnova Corporation, Shanghai Henlius Biotech Inc., Prestige Biopharma Pte Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/herceptin-global-market-report

How Do Regional Dynamics Influence The Herceptin Market Performance?

North America was the largest region in the herceptin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the herceptin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=24236&type=smp

Browse Through More Reports Similar to the Global Herceptin Market 2025, By The Business Research Company

Cancer Biologics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Skin Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/skin-cancer-drugs-global-market-report

Pancreatic Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model